Empresa Biotech Acquisition Company
Acciones
BIOT
KYG1125A1085
Holding Companies
Resumen de negocios
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Michael Shleifer
CEO | Chief Executive Officer | 49 | - |
Thomas Fratacci
DFI | Director of Finance/CFO | 46 | 01/09/20 |
Ivan Jarry
COO | Chief Operating Officer | 45 | 01/09/20 |
Albert F. Hummel
CIO | Chief Investment Officer | 78 | 01/09/20 |
Tanguy Serra
PRN | Corporate Officer/Principal | 45 | 03/09/20 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Albert F. Hummel
CIO | Chief Investment Officer | 78 | 01/09/20 |
Bruno Montanari
BRD | Director/Board Member | 49 | 25/01/21 |
Paul D. Bernard
BRD | Director/Board Member | 55 | 25/01/21 |
Michael Shleifer
CEO | Chief Executive Officer | 49 | - |
Aaron Kim
BRD | Director/Board Member | 53 | 25/01/21 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 5 750 000 | 0 | 0 | 80,00 % |
Acción B | 1 | 23 000 000 | 23 000 000 ( 100,00 %) | 0 |
Información de la empresa
Varia. 1 de ene. | Capi. | |
---|---|---|
+190,94 % | 7128,94 M | |
+2,14 % | 982 M | |
+41,91 % | 872 M | |
+26,98 % | 820 M | |
+1,72 % | 664 M | |
+5,92 % | 648 M | |
-.--% | 600 M | |
+3,61 % | 503 M | |
-.--% | 500 M |